Cellsway is a biotechnology company that has developed a liquid biopsy platform that uses a simple blood sample to monitor cancer.
Cellsway has raised $390K in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Cellsway's investors include European Union, APY Ventures, Teknoloji Yatirim, TuBTAK, Invest 101.
Cellsway is headquartered in Nether Alderley, United Kingdom.
Cellsway is a biotechnology company that has developed a liquid biopsy platform that uses a simple blood sample to monitor cancer.
Cellsway is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellsway — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/cellsway. Accessed July 21, 2026.
VCBacked. (2024). Cellsway — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/cellsway
{{cite web |title=Cellsway — Funding & Investors |url=https://www.vcbacked.co/company/cellsway |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated